Trials / Conditions / Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
5 registered clinical trials studyying Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMI NCT07220187 | SWOG Cancer Research Network | Phase 3 |
| Recruiting | Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation NCT06735664 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From NCT06247540 | Northwestern University | Phase 2 |
| Recruiting | Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome NCT05873712 | Aseel Alsouqi | Phase 2 |
| Completed | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma NCT03892044 | David Bond, MD | Phase 1 |